Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Alzheimer's disease is characterised by memory loss and difficulties with thinking. These
problems may be due to a deficiency in a brain chemical called acetylcholine. Acetylcholine
helps transmit messages between nerve cells. Acetylcholine is degraded by an enzyme called
"acetylcholinesterase". ZT-1 is a new drug derived from a plant extract already used in China
for memory disorders, which blocks the action of the enzyme and restores adequate levels of
acetylcholine.
This study will test the safety and efficacy of ZT-1 in the treatment of patients with
Alzheimer's disease.
BRAINz stands for Better Recollection for Alzheimer's patients with the Implant of ZT-1.